Fundamentally, the liberal government reelection has tainted BAL's outlook. A2M and BAL didn't react positively to more of the same. For BAL, more of the same is no SAMR and continual market share shrinkage. Is the market expecting a downgrade? Down $2.50 from recent highs following the nothing ViPlus announcement that may impact BAL's SAMR ambitions. Why would anyone hold a stock that has shorters flooding its register and very little positive news in the pipeline? Ask yourself.
BAL Price at posting:
$9.50 Sentiment: Sell Disclosure: Held